CANF
Can-Fite BioPharma Ltd.Company with tickers: CANF
CIK
1536196
CUSIP
13471N409
Shares Outstanding
2,142,547
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $743,000 | USD | 2023-12-31 | 20-F | 2026-03-26 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $8,938,000 | USD | 2023-12-31 | 20-F | 2026-03-26 |
| Research & Development | $5,983,000 | USD | 2023-12-31 | 20-F | 2026-03-26 |
| Operating Income | $-8,195,000 | USD | 2023-12-31 | 20-F | 2026-03-26 |
| Net Income | $-7,634,000 | USD | 2023-12-31 | 20-F | 2026-03-26 |
| EPS (Basic) | $-17.92 | USD/shares | 2023-12-31 | 20-F | 2026-03-26 |
| EPS (Diluted) | $-17.92 | USD/shares | 2023-12-31 | 20-F | 2026-03-26 |